Evidence map›Paper›PMID 38570401›Full record

ArticleMikrochimica acta2024

SERS biosensor with plastic antibodies for detection of a cancer biomarker protein.

Daniela Oliveira, Mariana C C G Carneiro, Felismina T C Moreira

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniela OliveiraCIETI - LabRISE-School of Engineering, Polytechnic of Porto, R. Dr. António Bernardino de Almeida, 431, 4249-015, Porto, Portugal.
Mariana C C G CarneiroCIETI - LabRISE-School of Engineering, Polytechnic of Porto, R. Dr. António Bernardino de Almeida, 431, 4249-015, Porto, Portugal.
Felismina T C MoreiraCIETI - LabRISE-School of Engineering, Polytechnic of Porto, R. Dr. António Bernardino de Almeida, 431, 4249-015, Porto, Portugal. ftm@isep.ipp.pt.ORCID http://orcid.org/0000-0003-4237-8952
Polytechnic Institute of Porto · PT

Funding

PhD grant (FCT) SFRH/BD/137832/2018.
6 · The paper itself

Abstract

Surface-enhanced Raman scattering (SERS) is a powerful method for detecting breast cancer-specific biomarkers due to its extraordinary enhancement effects obtained by localized surface plasmon resonance (LSPR) in metallic nanostructures at hotspots. In this research, gold nanostars (AuNSs) were used as SERS probes to detect a cancer biomarker at very low concentrations. To this end, we combined molecularly imprinted polymers (MIPs) as a detection layer with SERS for the detection of the biomarker CA 15-3 in point-of-care (PoC) analysis. This required two main steps: (i) the deposition of MIPs on a gold electrode, followed by a second step (ii) antibody binding with AuNSs containing a suitable Raman reporter to enhance Raman signaling (SERS). The MPan sensor was prepared by electropolymerization of the monomer aniline in the presence of CA 15-3. The template molecule was then extracted from the polymer using sodium dodecyl sulfate (SDS). In parallel, a control material was prepared in the absence of the protein (NPan). Surface modification for the control was performed using electrochemical techniques such as cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The performance of the sensor was evaluated using the SERS technique, in which the MPan sensor is first incubated with the protein and then exposed to the SERS probe. Under optimized conditions, the device showed a linear response to CA 15-3 concentrations from 0.016 to 248.51 U mL

Indexed as

Biosensing TechniquesMolecular ImprintingNeoplasmsAntibodiesBiomarkers, TumorGoldAntibodiesBiomarkers, TumorGoldCancer biomarkers, BiosensorMolecular imprintingSurface-enhanced Raman scattering

Identifiers

PMID38570401
PMCPMC10991021
OpenAlexW4393946116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.